General Information of the Compound
Compound ID |
CP0783440
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
3-ethyl-5-((1R,3R)-1-(1-ethyl-1H-pyrazol-4-yl)-3-(4-(5-fluoropyridin-2-yl)-1H-imidazol-2-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)-1,3,4-oxadiazol-2(3H)-one
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C28H26FN9O2
|
||||||||||||||||||
Molecular Weight |
539.575
|
||||||||||||||||||
Canonical SMILES |
CCn1cc([C@@]2(c3nn(CC)c(=O)o3)N[C@@H](c3nc(-c4ccc(F)cn4)c[nH]3)Cc3c2[nH]c2ccccc32)cn1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C28H26FN9O2/c1-3-37-15-16(12-32-37)28(26-36-38(4-2)27(39)40-26)24-19(18-7-5-6-8-20(18)33-24)11-22(35-28)25-31-14-23(34-25)21-10-9-17(29)13-30-21/h5-10,12-15,22,33,35H,3-4,11H2,1-2H3,(H,31,34)/t22-,28-/m1/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
QQLVWLYBRMDMSR-SKCUWOTOSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound